Senior Director, Outcomes, Value & Access

Kymera Therapeutics•Watertown, MA

18h•$235,000 - $330,000

About The Position

The Senior Director, Outcomes, Value & Access will serve as Kymera’s strategic leader for health economics, real-world evidence (RWE), value communication, and payer-relevant medical strategy across the pipeline. Reporting to the VP of Medical Affairs, this role will shape and execute the company’s integrated outcomes and access strategy to support optimized patient access, informed clinical decision-making, and successful product commercialization. The ideal candidate is an experienced HEOR leader with deep immunology expertise (dermatology and/or respiratory strongly preferred), a proven track record preparing for and supporting launches, and significant experience engaging national and regional payer stakeholders.

Requirements

Advanced degree: PharmD, PhD, MD, MS/MPH in HEOR, Epidemiology, or related field.
10+ years of experience in Medical Affairs, HEOR, Market Access, or related roles in the biopharmaceutical industry.
Demonstrated leadership in building or expanding HEOR or Medical Value/Access functions.
Strong therapeutic experience in immunology, with dermatology and/or respiratory as a plus.
Proven track record developing payer-focused HEOR strategy, RWE programs, value communication tools, and AMCP dossiers.
Experience engaging directly with national and regional payer decision-makers.
Strong understanding of U.S. healthcare economics, HTA landscapes, and evolving value-based frameworks.
Ability to work collaboratively in a fast-paced, science-driven, cross-functional environment.

Nice To Haves

Experience supporting early-stage to launch-stage products in specialty immunology.
Prior leadership of field-based payer medical teams.
Global or ex-U.S. HEOR/HTA exposure.
Experience in small or mid-size biotech environments.

Responsibilities

Lead the development and execution of Kymera’s Medical Outcomes, Value & Access strategy across the immunology portfolio.
Serve as a core member of the Medical Affairs Team, advising on evidence generation, clinical strategy, and payer-relevant insights.
Drive cross-functional alignment on value strategy across Medical Affairs, HEOR, Market Access, Clinical Development, Regulatory, Commercial, and Global teams.
Oversee HEOR strategy, including economic modeling, treatment-pattern studies, and comparative-effectiveness analyses.
Guide development and validation of economic models (e.g., budget impact, cost-effectiveness) to support payer decision-making.
Lead creation of AMCP dossiers, value narratives, and scientific payer resources.
Design and oversee RWE plans, including study concept refinement, protocol development, external data partnerships, and post-marketing evidence strategy.
Partner with Clinical Development and Data Science teams to integrate outcomes-focused endpoints into clinical trial design.
Build and maintain relationships with U.S. payer organizations, HTAs, integrated delivery networks, and employer groups to communicate clinical and economic value.
Lead scientific exchange with medical directors, formulary decision-makers, and population-health leaders.
Conduct advisory boards on HEOR, RWE, and access-related topics.
Provide leadership for value and access–related launch preparation.
Collaborate with Market Access to ensure scientific accuracy and strategic alignment of access resources.
Serve as lead on health technology assessment (HTA) readiness for future ex-US markets, in partnership with global teams.
Support field medical teams with training on HEOR, RWE, and payer communication.
Build and lead a high-performing Outcomes, Value & Access team, fostering a culture of scientific excellence, collaboration, and accountability.
Manage budgets, timelines, and resource allocation across projects and vendors.